Amedeo Smart

Free Medical Literature Service



Breast Cancer

  Free Subscription

Articles published in
    July 2021
  1. ALIYARI SEREJ Z, Ebrahimi A, Kazemi T, Najafi S, et al
    NANOG gene suppression and replacement of let-7 modulate the stemness, invasion, and apoptosis in breast cancer.
    Gene. 2021 Jul 15:145844. doi: 10.1016/j.gene.2021.145844.
    >> Share

  2. MURAD R, Avanes A, Ma X, Geng S, et al
    Transcriptome and chromatin landscape changes associated with trastuzumab resistance in HER2+ breast cancer cells.
    Gene. 2021 Jul 2:145808. doi: 10.1016/j.gene.2021.145808.
    >> Share

  3. FENG Y, Cai H, Huang X, Li Z, et al
    Active MT1-MMP is tethered to collagen fibers in DDR2-containing remnants.
    Gene. 2021;788:145673.
    >> Share

    June 2021
  4. GYAN E, Owiredu WKBA, Ahenkorah-Fondjo L, Jackson AM, et al
    A review of the racial heterogeneity of breast cancer stem cells.
    Gene. 2021 Jun 28:145805. doi: 10.1016/j.gene.2021.145805.
    >> Share

    May 2021
  5. KUMAR A, Dhillon A, Manjegowda MC, Singh N, et al
    Estrogen suppresses HOXB2 expression via ERalpha in breast cancer cells.
    Gene. 2021 May 29:145746. doi: 10.1016/j.gene.2021.145746.
    >> Share

  6. ROYCHOWDHURY A, Jondhale M, Saldanha E, Ghosh D, et al
    Landscape of Toll-like receptors expression in tumor microenvironment of Triple Negative Breast Cancer (TNBC): distinct roles of TLR4 and TLR8.
    Gene. 2021 May 19:145728. doi: 10.1016/j.gene.2021.145728.
    >> Share

  7. PARAMASIVAM OVIYA R, Gopal G, Singh Shirley S, Sridevi V, et al
    Mitochondrial Ribosomal Small Subunit proteins (MRPS) MRPS6 and MRPS23 show dysregulation in breast cancer affecting tumorigenic cellular processes.
    Gene. 2021 May 5:145697. doi: 10.1016/j.gene.2021.145697.
    >> Share

    March 2021
  8. JANANI SK, Dhanabal SP, Sureshkumar R, Nikitha Upadhyayula SS, et al
    Guardian of genome on the tract: wild type p53-mdm2 complex inhibition in healing the breast cancer.
    Gene. 2021 Mar 31:145616. doi: 10.1016/j.gene.2021.145616.
    >> Share

    January 2021
  9. TANDON M, Othman AH, Winogradzki M, Pratap J, et al
    Bone metastatic breast cancer cells display downregulation of PKC-zeta with enhanced glutamine metabolism.
    Gene. 2021 Jan 11:145419. doi: 10.1016/j.gene.2021.145419.
    >> Share

    November 2020
  10. KANUMURI R, Saravanan R, Pavithra V, Sundaram S, et al
    Current trends and opportunities in targeting p21 activated kinase-1(PAK1) for therapeutic management of breast cancers.
    Gene. 2020;760:144991.
    >> Share

    September 2020
  11. ZHANG XY, Mao L
    Circular RNA Circ_0000442 Acts as a Sponge of MiR-148b-3p to Suppress Breast Cancer via PTEN/PI3K/Akt Signaling Pathway.
    Gene. 2020 Sep 3:145113. doi: 10.1016/j.gene.2020.145113.
    >> Share

    August 2020
  12. WANG J, Yang Z, Zhang C, Ouyang J, et al
    A Four-Gene Signature in the Tumor Microenvironment That Significantly Associates with the Prognosis of Patients with Breast Cancer.
    Gene. 2020 Aug 10:145049. doi: 10.1016/j.gene.2020.145049.
    >> Share

  13. DOMINGUEZ-DE-LA-CRUZ E, de Lourdes Munoz M, Perez-Munoz A, Garcia-Hernandez N, et al
    Reduced mitochondrial DNA copy number is associated with the haplogroup, and some clinical features of breast cancer in Mexican patients.
    Gene. 2020 Aug 9:145047. doi: 10.1016/j.gene.2020.145047.
    >> Share

  14. RAJAGOPAL T, Seshachalam A, Akshaya RL, Kumar Rathnam K, et al
    Association of HOTAIR (rs920778 and rs1899663) and NME1 (rs16949649 and rs2302254) gene polymorphisms with breast cancer risk in India.
    Gene. 2020 Aug 8:145033. doi: 10.1016/j.gene.2020.145033.
    >> Share

  15. NOLAN J, Mahdi AF, Dunne CP, Kiely PA, et al
    Collagen and fibronectin promote an aggressive cancer phenotype in breast cancer cells but drive autonomous gene expression patterns.
    Gene. 2020 Aug 2:145024. doi: 10.1016/j.gene.2020.145024.
    >> Share

    July 2020
  16. JAMALZEI B, Karami Tehrani FS, Atri M
    Evaluation of LDL receptor and Scavenger Receptor, Class B, Type 1 in the malignant and benign breast tumors: The correlation with the expression of miR-199a-5p, miR-199b-5p and miR-455-5p.
    Gene. 2020;749:144720.
    >> Share

  17. XU T, Zhang S, Qiu D, Li X, et al
    Association between matrix metalloproteinase 9 polymorphisms and breast cancer risk: An updated meta-analysis and trial sequential analysis.
    Gene. 2020;759:144972.
    >> Share

  18. KUSOGLU A, Bagca BG, Ay NPO, Gunduz C, et al
    Telomerase inhibition regulates EMT mechanism in breast cancer stem cells.
    Gene. 2020 Jul 29:145001. doi: 10.1016/j.gene.2020.145001.
    >> Share

  19. GUO L, Chen B, Zhang G, Wang Y, et al
    The transcription factor CBFB mutations indicate an improved survival in HR+/HER2- breast cancer.
    Gene. 2020 Jul 22:144970. doi: 10.1016/j.gene.2020.144970.
    >> Share

  20. DU JX, Chen C, Luo YH, Cai JL, et al
    Establishment and validation of a novel autophagy-related gene signature for patients with breast cancer.
    Gene. 2020 Jul 21:144974. doi: 10.1016/j.gene.2020.144974.
    >> Share

    June 2020
  21. CAI Z, Zhang M, Boafo Kwantwi L, Bi X, et al
    Breast cancer cells promote self-migration by secreting interleukin 8 to induce NET formation.
    Gene. 2020 Jun 13:144902. doi: 10.1016/j.gene.2020.144902.
    >> Share

  22. RAHMANI F, Taddayon Tabrizi A, Hashemian P, Alijannejad S, et al
    Role of regulatory miRNAs of the Wnt/ beta-catenin signaling pathway in tumorigenesis of breast cancer.
    Gene. 2020 Jun 10:144892. doi: 10.1016/j.gene.2020.144892.
    >> Share

    May 2020
  23. TENHUNEN J, Kokkola T, Huovinen M, Rahnasto-Rilla M, et al
    Impact of structurally diverse BET inhibitors on SIRT1.
    Gene. 2020;741:144558.
    >> Share

  24. JIA R, Zhao H, Jia M
    Identification of co-expression modules and potential biomarkers of breast cancer by WGCNA.
    Gene. 2020;750:144757.
    >> Share

    April 2020
  25. SUN L, Shi C, Liu S, Zhang E, et al
    Overexpression of NuSAP1 is predictive of an unfavourable prognosis and promotes proliferation and invasion of triple-negative breast cancer cells via the Wnt/beta-catenin/EMT signalling axis.
    Gene. 2020 Apr 13:144657. doi: 10.1016/j.gene.2020.144657.
    >> Share

    March 2020
  26. WU Y, Huang D, Zhang H, Weng X, et al
    The frequency of PTEN germline mutations in Chinese breast cancer patients: the PTEN gene may not be closely associated with breast cancer in the Chinese population.
    Gene. 2020 Mar 28:144630. doi: 10.1016/j.gene.2020.144630.
    >> Share

    February 2020
  27. DAI J, Chen Y, Gong Y, Gu D, et al
    Association of microRNA-27a rs895819 polymorphism with the risk of cancer: An updated meta-analysis.
    Gene. 2020;728:144185.
    >> Share

  28. DOULABI MSH, Ghaedi K, Ranji N, Koohpar ZK, et al
    rs1016860 of BCL2 3'UTR associates with hsa-miR-629-5p binding potential in breast cancer and gastric cancer in isfahan population.
    Gene. 2020 Feb 17:144457. doi: 10.1016/j.gene.2020.144457.
    >> Share

  29. RAHMANI F, Ferns GA, Talebian S, Nourbakhsh M, et al
    Role of regulatory miRNAs of the PI3K/AKT signaling pathway in the pathogenesis of breast cancer.
    Gene. 2020 Feb 8:144459. doi: 10.1016/j.gene.2020.144459.
    >> Share

  30. ABUBAKR BABTEEN N, Fawzy MS, Alelwani W, Ayiad Alharbi R, et al
    Signal peptide missense variant in cancer-brake gene CTLA4 and breast cancer outcomes.
    Gene. 2020 Feb 7:144435. doi: 10.1016/j.gene.2020.144435.
    >> Share

  31. NAJJARY S, Mohammadzadeh R, Mokhtarzadeh A, Mohammadi A, et al
    Role of miR-21 as an authentic oncogene in mediating drug resistance in breast cancer.
    Gene. 2020 Feb 5:144453. doi: 10.1016/j.gene.2020.144453.
    >> Share

    January 2020
  32. ZHANG H, Cui X, Cao A, Li X, et al
    ITGA3 interacts with VASP to regulate stemness and epithelial-mesenchymal transition of breast cancer cells.
    Gene. 2020 Jan 25:144396. doi: 10.1016/j.gene.2020.144396.
    >> Share

  33. POURBAGHER R, Akhavan-Niaki H, Jorsaraei SGA, Fattahi S, et al
    Targeting LA7 breast cancer stem cells of rat through repressing the genes of stemness-related transcription factors using three different biological fluids.
    Gene. 2020 Jan 21:144381. doi: 10.1016/j.gene.2020.144381.
    >> Share

  34. WANG X, Su D, Qin Z, Chen Z, et al
    Identification of FOXN4 as a tumor suppressor of breast carcinogenesis via the activation of TP53 and deactivation of Notch signaling.
    Gene. 2020;722:144057.
    >> Share

    December 2019
  35. DASTMALCHI N, Safaralizadeh R, Baradaran B, Hosseinpourfeizi M, et al
    An update review of deregulated tumor suppressive microRNAs and their contribution in various molecular subtypes of breast cancer.
    Gene. 2019 Dec 26:144301. doi: 10.1016/j.gene.2019.144301.
    >> Share

  36. XIE W, Zhang H, Qin S, Zhang J, et al
    The expression and clinical significance of secretory leukocyte proteinase inhibitor (SLPI) in mammary carcinoma using bioinformatics analysis.
    Gene. 2019;720:144088.
    >> Share

  37. AL-EITAN LN, Rababa'h DM
    Correlation between a variable number tandem repeat (VNTR) polymorphism in SMYD3 gene and breast cancer: a genotype-phenotype study.
    Gene. 2019 Dec 10:144281. doi: 10.1016/j.gene.2019.144281.
    >> Share

    November 2019
  38. MORAIS-RODRIGUES F, Silv Erio-Machado R, Kato RB, Rodrigues DLN, et al
    Analysis of the microarray gene expression for breast cancer progression after the application modified logistic regression.
    Gene. 2019 Nov 21:144168. doi: 10.1016/j.gene.2019.144168.
    >> Share

    September 2019
  39. QI L, Yao Y, Zhang T, Feng F, et al
    A four-mRNA model to improve the prediction of breast cancer prognosis.
    Gene. 2019 Sep 4:144100. doi: 10.1016/j.gene.2019.144100.
    >> Share

  40. ZOU X, Li M, Huang Z, Zhou X, et al
    Circulating miR-532-502 cluster derived from chromosome X as biomarkers for diagnosis of breast cancer.
    Gene. 2019 Sep 4:144104. doi: 10.1016/j.gene.2019.144104.
    >> Share

    August 2019
  41. WANG H, Xu B, Shi J
    N6-methyladenosine METTL3 promotes the breast cancer progression via targeting Bcl-2.
    Gene. 2019 Aug 24:144076. doi: 10.1016/j.gene.2019.144076.
    >> Share

  42. ORS KUMOGLU G, Doskaya M, Gulce Iz S
    The biomarker features of miR-145-3p determined via meta-analysis validated by qRT-PCR in metastatic cancer cell lines.
    Gene. 2019;710:341-353.
    >> Share

  43. NAZIR SU, Kumar R, Singh A, Khan A, et al
    Corrigendum to "Breast cancer invasion and progression by MMP-9 through Ets-1 transcription factor" [Gene 711 (2019) 143952].
    Gene. 2019 Aug 1:144013. doi: 10.1016/j.gene.2019.144013.
    >> Share

    July 2019
  44. TOKGUN PE, Tokgun O, Kurt S, Tomatir AG, et al
    MYC-driven regulation of long non-coding RNA profiles in breast cancer cells.
    Gene. 2019 Jul 18:143955. doi: 10.1016/j.gene.2019.143955.
    >> Share

  45. RAMEZANI S, Sharafshah A, Mirzanejad L, Hadavi M, et al
    Association of PARP1 rs4653734, rs907187 and rs1136410 variants with breast cancer risk among Iranian women.
    Gene. 2019;712:143954.
    >> Share

    June 2019
  46. NAZIR SU, Kumar R, Singh A, Khan A, et al
    Breast cancer invasion and progression by MMP-9 through Ets-1 transcription factor.
    Gene. 2019 Jun 29:143952. doi: 10.1016/j.gene.2019.143952.
    >> Share

  47. YARAHMADI S, Abdolvahabi Z, Hesari Z, Tavakoli-Yaraki M, et al
    Inhibition of sirtuin 1 deacetylase by miR-211-5p provides a mechanism for the induction of cell death in breast cancer cells.
    Gene. 2019 Jun 17. pii: S0378-1119(19)30589-X. doi: 10.1016/j.gene.2019.
    >> Share

  48. FENG T, Zhang P, Sun Y, Wang Y, et al
    High throughput sequencing identifies breast cancer-secreted exosomal LncRNAs initiating pulmonary pre-metastatic niche formation.
    Gene. 2019 Jun 6. pii: S0378-1119(19)30552-9. doi: 10.1016/j.gene.2019.
    >> Share

  49. KASA P, Farran B, Prasad GLV, Nagaraju GP, et al
    Aquaporins in female specific cancers.
    Gene. 2019;700:60-64.
    >> Share

    May 2019
  50. XU X, Yang J, Zhou W, Wang L, et al
    Genetic variations within alternative splicing associated genes are associated with breast cancer susceptibility in Chinese women.
    Gene. 2019 May 9. pii: S0378-1119(19)30484-6. doi: 10.1016/j.gene.2019.
    >> Share

    April 2019
  51. WU G, Niu M, Qin J, Wang Y, et al
    Inactivation of Rab27B-dependent signaling pathway by calycosin inhibits migration and invasion of ER-negative breast cancer cells.
    Gene. 2019 Apr 16. pii: S0378-1119(19)30344-0. doi: 10.1016/j.gene.2019.
    >> Share

  52. BU Y, Shi L, Yu D, Liang Z, et al
    CDCA8 is a key mediator of estrogen-stimulated cell proliferation in breast cancer cells.
    Gene. 2019;703:1-6.
    >> Share

    March 2019
  53. MUKUND V, Saddala MS, Farran B, Mannavarapu M, et al
    Molecular docking studies of angiogenesis target protein HIF-1alpha and genistein in breast cancer.
    Gene. 2019;701:169-172.
    >> Share

  54. SAFARI MR, Rezaei FM, Dehghan A, Noroozi R, et al
    Genomic variants within the long non-coding RNA H19 confer risk of breast cancer in Iranian population.
    Gene. 2019 Mar 22. pii: S0378-1119(19)30293-8. doi: 10.1016/j.gene.2019.
    >> Share

  55. AFSHAR E, Hashemi-Arabi M, Salami S, Peirouvi T, et al
    Screening of acetaminophen-induced alterations in epithelial-to-mesenchymal transition-related expression of microRNAs in a model of stem-like triple-negative breast cancer cells: The possible functional impacts.
    Gene. 2019 Mar 18. pii: S0378-1119(19)30271-9. doi: 10.1016/j.gene.2019.
    >> Share

  56. ZHANG L, Chen T, Yan L, Xu H, et al
    MiR-155-3p acts as a tumor suppressor and reverses paclitaxel resistance via negative regulation of MYD88 in human breast cancer.
    Gene. 2019 Mar 13. pii: S0378-1119(19)30200-8. doi: 10.1016/j.gene.2019.
    >> Share

    February 2019
  57. YOUNES N, Zayed H
    Genetic epidemiology of ovarian cancer in the 22 Arab countries: A systematic review.
    Gene. 2019;684:154-164.
    >> Share

    January 2019
  58. ZHONG C, Mai Y, Gao H, Zhou W, et al
    Mitochondrial targeting of TR3 is involved in TPA induced apoptosis in breast cancer cells.
    Gene. 2019 Jan 11. pii: S0378-1119(19)30032-0. doi: 10.1016/j.gene.2018.
    >> Share

    November 2018
  59. LI J, Li B, Jiang Q, Zhang Y, et al
    Do genetic polymorphisms of the vitamin D receptor contribute to breast/ovarian cancer? A systematic review and network meta-analysis.
    Gene. 2018;677:211-227.
    >> Share

  60. ORANGI E, Motovali-Bashi M
    Evaluation of miRNA-9 and miRNA-34a as potential biomarkers for diagnosis of breast cancer in Iranian women.
    Gene. 2018;687:272-279.
    >> Share

    October 2018
  61. ZHOU J, Pei Y, Chen G, Cao C, et al
    SPC24 Regulates breast cancer progression by PI3K/AKT signaling.
    Gene. 2018;675:272-277.
    >> Share

  62. MA R, Zhai X, Zhu X, Zhang L, et al
    LINC01585 functions as a regulator of gene expression by the CAMP/CREB signaling pathway in breast cancer.
    Gene. 2018 Oct 23. pii: S0378-1119(18)31102-8. doi: 10.1016/j.gene.2018.
    >> Share

  63. JAHANGIRI R, Jamialahmadi K, Gharib M, Razavi AE, et al
    Expression and clinicopathological significance of DNA methyltransferase 1, 3A and 3B in tamoxifen-treated breast cancer patients.
    Gene. 2018 Oct 22. pii: S0378-1119(18)31099-0. doi: 10.1016/j.gene.2018.
    >> Share

  64. SHI S, Chen X, Liu H, Yu K, et al
    LGR5 acts as a target of miR-340-5p in the suppression of cell progression and drug resistance in breast cancer via Wnt/beta-catenin pathway.
    Gene. 2018 Oct 6. pii: S0378-1119(18)31039-4. doi: 10.1016/j.gene.2018.
    >> Share

    August 2018
  65. MAQBOOL SN, Nazeer HS, Rafiq M, Javed A, et al
    Bridging the gap by discerning SNPs in linkage disequilibrium and their role in breast cancer.
    Gene. 2018 Aug 14. pii: S0378-1119(18)30762-5. doi: 10.1016/j.gene.2018.
    >> Share

  66. JANAKI RAMAIAH M, Vaishnave S
    BMI1 and PTEN are key determinants of breast cancer therapy: A plausible therapeutic target in breast cancer.
    Gene. 2018 Aug 7. pii: S0378-1119(18)30872-2. doi: 10.1016/j.gene.2018.
    >> Share

    July 2018
    Tree-based machine learning algorithms identified minimal set of miRNA biomarkers for breast cancer diagnosis and molecular subtyping.
    Gene. 2018 Jul 25. pii: S0378-1119(18)30836-9. doi: 10.1016/j.gene.2018.
    >> Share

  68. SADAF, Habib M, Khan MA, Najm MZ, et al
    Hypermethylated LATS2 gene with decreased expression in female breast cancer: A case control study from North India.
    Gene. 2018 Jul 12. pii: S0378-1119(18)30807-2. doi: 10.1016/j.gene.2018.
    >> Share

  69. JIANG M, Xiao Y, Liu D, Luo N, et al
    Overexpression of long noncoding RNA LINC01296 indicates an unfavorable prognosis and promotes tumorigenesis in breast cancer.
    Gene. 2018 Jul 4. pii: S0378-1119(18)30773-X. doi: 10.1016/j.gene.2018.
    >> Share

    June 2018
  70. AL-OTHMAN N, Hammad H, Ahram M
    Dihydrotestosterone regulates expression of CD44 via miR-328-3p in triple-negative breast cancer cells.
    Gene. 2018 Jun 28. pii: S0378-1119(18)30755-8. doi: 10.1016/j.gene.2018.
    >> Share

  71. ULKER D, Ersoy YE, Gucin Z, Muslumanoglu M, et al
    Downregulation of SCARA5 may contribute to breast cancer via promoter hypermethylation.
    Gene. 2018 Jun 13. pii: S0378-1119(18)30687-5. doi: 10.1016/j.gene.2018.
    >> Share

  72. HESARI Z, Nourbakhsh M, Hosseinkhani S, Abdolvahabi Z, et al
    Down-regulation of NAMPT expression by mir-206 reduces cell survival of breast cancer cells.
    Gene. 2018 Jun 7. pii: S0378-1119(18)30672-3. doi: 10.1016/j.gene.2018.
    >> Share

    May 2018
  73. XU J, Zhang W, Tang L, Chen W, et al
    Epithelial-mesenchymal transition induced PAI-1 is associated with prognosis of triple-negative breast cancer patients.
    Gene. 2018 May 23. pii: S0378-1119(18)30586-9. doi: 10.1016/j.gene.2018.
    >> Share

  74. RAHMAN S, Zayed H
    Breast cancer in the GCC countries: A focus on BRCA1/2 and non-BRCA1/2 genes.
    Gene. 2018 May 16. pii: S0378-1119(18)30534-1. doi: 10.1016/j.gene.2018.
    >> Share

  75. BAGHI N, Bakhshinejad B, Keshavarz R, Babashah S, et al
    Dendrosomal nanocurcumin and exogenous p53 can act synergistically to elicit anticancer effects on breast cancer cells.
    Gene. 2018 May 10. pii: S0378-1119(18)30508-0. doi: 10.1016/j.gene.2018.
    >> Share

  76. REZAIE Z, Ardeshirylajimi A, Ashkezari MD
    Improved anticancer properties of stem cells derived exosomes by prolonged release from PCL nanofibrous structure.
    Gene. 2018 May 2. pii: S0378-1119(18)30480-3. doi: 10.1016/j.gene.2018.
    >> Share

    March 2018
  77. FEI HR, Li ZJ, Ying-Zhang, Yue-Liu, et al
    HBXIP regulates etoposide-induced cell cycle checkpoints and apoptosis in MCF-7 human breast carcinoma cells.
    Gene. 2018;647:39-47.
    >> Share

  78. RAGHAVAN S, Venkatraman G, Rayala SK
    Cloning and functional characterization of human Pak1 promoter by steroid hormones.
    Gene. 2018;646:120-128.
    >> Share

  79. XIAO B, Zhang W, Chen L, Hang J, et al
    Analysis of the miRNA-mRNA-lncRNA network in human estrogen receptor-positive and estrogen receptor-negative breast cancer based on TCGA data.
    Gene. 2018 Mar 5. pii: S0378-1119(18)30238-5. doi: 10.1016/j.gene.2018.
    >> Share

    February 2018
  80. HEYDARI N, Nikbakhsh N, Sadeghi F, Farnoush N, et al
    Overexpression of serum MicroRNA-140-3p in premenopausal women with newly diagnosed breast cancer.
    Gene. 2018 Feb 20. pii: S0378-1119(18)30167-7. doi: 10.1016/j.gene.2018.
    >> Share

  81. SINGH PK, Mistry K, Haritha C, Rank DN, et al
    Exploring the deleterious SNPs in XRCC4 gene using computational approach and studying their association with breast cancer in the population of West India.
    Gene. 2018 Feb 13. pii: S0378-1119(18)30176-8. doi: 10.1016/j.gene.2018.
    >> Share

  82. GHALI R, Al-Mutawa MA, Al-Ansari AK, Zaied S, et al
    Differential association of ESR1 and ESR2 gene variants with the risk of breast cancer and associated features: A case-control study.
    Gene. 2018 Feb 4. pii: S0378-1119(18)30140-9. doi: 10.1016/j.gene.2018.
    >> Share

  83. LI XP, Lan JY, Liu DQ, Zhou H, et al
    OCA2 rs4778137 polymorphism predicts survival of breast cancer patients receiving neoadjuvant chemotherapy.
    Gene. 2018 Feb 1. pii: S0378-1119(18)30121-5. doi: 10.1016/j.gene.2018.
    >> Share

    January 2018
  84. CHEN J, Jiang Y, Zhou J, Liu S, et al
    Evaluation of CpG-SNPs in miRNA promoters and risk of breast cancer.
    Gene. 2018 Jan 24. pii: S0378-1119(18)30085-4. doi: 10.1016/j.gene.2018.
    >> Share

  85. DANESH H, Hashemi M, Bizhani F, Hashemi SM, et al
    Association study of miR-100, miR-124-1, miR-218-2, miR-301b, miR-605, and miR-4293 polymorphisms and the risk of breast cancer in a sample of Iranian population.
    Gene. 2018 Jan 6. pii: S0378-1119(18)30032-5. doi: 10.1016/j.gene.2018.
    >> Share

    December 2017
  86. KAR S, Patra SK
    Overexpression of OCT4 induced by modulation of histone marks plays crucial role in breast cancer progression.
    Gene. 2017 Dec 1. pii: S0378-1119(17)31043-0. doi: 10.1016/j.gene.2017.
    >> Share

    November 2017
  87. KLASSEN LMB, Chequin A, Manica GCM, Biembengut IV, et al
    MMP9 gene expression regulation by intragenic epigenetic modifications in breast cancer.
    Gene. 2017 Nov 18. pii: S0378-1119(17)31018-1. doi: 10.1016/j.gene.2017.
    >> Share

  88. PENG R, Luo C, Guo Q, Cao J, et al
    Association analyses of genetic variants in long non-coding RNA MALAT1 with breast cancer susceptibility and mRNA expression of MALAT1 in Chinese Han population.
    Gene. 2017 Nov 13. pii: S0378-1119(17)30956-3. doi: 10.1016/j.gene.2017.
    >> Share

    October 2017
  89. JANAKI RAMAIAH M, Naushad SM, Lavanya PON, Gayatri A, et al
    Epigenetic regulation of miR-200 as the potential strategy for the therapy against triple-negative breast cancer.
    Gene. 2017 Oct 13. pii: S0378-1119(17)30831-4. doi: 10.1016/j.gene.2017.
    >> Share

  90. ZHOU L, Gao HF, Liu DS, Feng JY, et al
    Gene expression profiling of brain metastatic cell from triple negative breast cancer: Understanding the molecular events.
    Gene. 2017 Oct 9. pii: S0378-1119(17)30833-8. doi: 10.1016/j.gene.2017.
    >> Share

    September 2017
  91. LAHIRI DK, Maloney B, Sambamurti K
    When figures and data contradict text: MiR346 is apparently reduced in breast cancer tissue, contrary to claims by a paper's author.
    Gene. 2017 Sep 6. pii: S0378-1119(17)30646-7. doi: 10.1016/j.gene.2017.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016